Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy
European Journal of Surgical Oncology · 2024
DOI: 10.1016/j.ejso.2024.108367 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2024. Verfasst von Ling-Kang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; Department of General Surgery, Fujian Medical Univers…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoadjuvant Therapy, Biomarkers, Tumor, Gastrectomy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: The effects of the dynamics of serum tumor markers (CA72-4, CEA, CA19-9, CA125 and AFP) before and after neoadjuvant chemotherapy (NACT) on the prognosis of gastric cancer(GC) patients remain unclear. METHODS: The training set contained 334 GC patients from Fujian Medical University Union Hospital (FJMUUH) and 113 GC patients in Qinghai University Affiliated Hospital (QhUAH) were used as an external validation set. Tumor marker regression load (ΔTMRL) indicator, including ΔCA72-4, ΔCEA, ΔCA19-9, ΔCA125, and ΔAFP, is defined as [(postNACT marker- preNACT marker)/preNACT marker]. Tumor marker regression load score (TMRLS) consists of ΔCA72-4, ΔCEA and ΔCA125. The predictive performance of the nomogram-TMRLS was evaluated using the area under the receiver operating characteristic(ROC) curve(AUC), decision curve analysis(DCA), and C-index. RESULTS: Patients from FJMUUH were divided into two groups, TMRLS-low and TMRLS-high, determined by R package maxstat. Survival analysis revealed a higher 3-year overall survival(OS) in the TMRLS-low than in the TMRLS-high group. The TMRLS-high group who received postoperative adjuvant chemotherapy(AC) showed a significantly higher 3-year OS rate than those who did not. Multivariate COX regression analysis indicated that TMRLS was an independent prognostic factor for OS. A nomogram for predicting OS based on TMRLS showed a significantly higher C-index and AUC than the ypTNM stage. The above results were also found in the QhUAH external validation cohort. CONCLUSION: TMRLS is a novel independent prognostic factor for GC who underwent NACT and a radical gastrectomy. Furthermore, the TMRLS-high group, who received postoperative AC, may achieve better survival outcomes. Notably, the predictive performance of the nomogram-TMRLS significantly outperformed that of the ypTNM stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; Key Laboratory of Ministry…
- Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, China.
Zitieren
APA
Zhang, L. K., Zheng, H. L., Zheng, H. H., Ma, Y. B., Lin, J. X., Xu, B. B., Xue, Z., Zheng, Z. W., Zheng, C. H., Huang, C. M., & Xie, J. W. (2024). Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.108367
Vancouver
Zhang LK, Zheng HL, Zheng HH, Ma YB, Lin JX, Xu BB, et al. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy. European Journal of Surgical Oncology. 2024. doi:10.1016/j.ejso.2024.108367
BibTeX
@article{Zhang2024,
author = {Zhang, Ling-Kang and Zheng, Hua-Long and Zheng, Hong-Hong and Ma, Yu-Bin and Lin, Jian-Xian and Xu, Bin-Bin and Xue, Zhen and Zheng, Zhi-Wei and Zheng, Chao-Hui and Huang, Chang-Ming and Xie, Jian-Wei},
title = {Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy},
journal = {European Journal of Surgical Oncology},
year = {2024},
doi = {10.1016/j.ejso.2024.108367}
}
EUVIMED